ADVANCED PANCREATIC CANCER
Clinical trials for ADVANCED PANCREATIC CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED PANCREATIC CANCER trials appear
Sign up with your email to follow new studies for ADVANCED PANCREATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug ProAgio tested in patients with advanced cancers
Disease control CompletedThis early-stage trial tested a new drug, ProAgio, in 46 people with advanced solid tumors, including pancreatic cancer, who had already tried other treatments. The main goal was to find a safe dose and check for side effects. The study did not aim to cure the disease, but to con…
Matched conditions: ADVANCED PANCREATIC CANCER
Phase: PHASE1 • Sponsor: ProDa BioTech, LLC • Aim: Disease control
Last updated May 17, 2026 13:53 UTC
-
Pancreatic cancer trial aims to match patients to best chemo
Knowledge-focused CompletedThis study tested two standard chemotherapy combinations in 150 people with untreated, advanced pancreatic cancer. Researchers compared how well each drug worked and also analyzed tumor samples to find biological markers that could predict which treatment is best for each patient…
Matched conditions: ADVANCED PANCREATIC CANCER
Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated May 04, 2026 16:22 UTC